Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,64M | Automatic Disposition | 82,05 - 82,58 | 1,07M | -1,84% |
| 2026-05-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -4,13k | 252,16k | Derivative Exercise and Sale | 22,86 - 84,60 | 165,14k | - |
| 2026-05-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -1,38k | 116,33k | Automatic Disposition | 84,60 | 165,14k | -0,83% |
| 2026-05-01 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 164,08k | Automatic Disposition | 81,02 - 83,16 | 173,37k | -1,14% |
| 2026-04-16 | Dr. Michael Thomas HendersonCEO & Director | 3,00k | 68,58k | Derivative Exercise and Retained Stock | 22,86 | 1,06M | 0,28% |
| 2026-04-16 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 180,00k | Automatic Disposition | 90,00 | 175,37k | -1,13% |
| 2026-04-08 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,65M | Automatic Disposition | 82,48 - 85,00 | 1,05M | -1,86% |
| 2026-04-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -4,13k | 254,94k | Derivative Exercise and Sale | 22,86 - 85,33 | 153,98k | - |
| 2026-04-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -1,38k | 117,38k | Automatic Disposition | 85,33 - 85,89 | 153,98k | -0,89% |
| 2026-04-01 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 170,02k | Automatic Disposition | 84,46 - 85,46 | 177,37k | -1,12% |
| 2026-03-25 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 170,00k | Automatic Disposition | 85,00 | 179,37k | -1,10% |
| 2026-03-11 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,50M | Automatic Disposition | 74,29 - 75,86 | 1,02M | -1,93% |
| 2026-03-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -1,38k | 99,23k | Automatic Disposition | 71,98 - 73,26 | 155,36k | -0,88% |
| 2026-03-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -4,13k | 197,30k | Derivative Exercise and Sale | 22,86 - 71,98 | 155,36k | - |
| 2026-03-02 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 140,43k | Automatic Disposition | 68,27 - 71,66 | 181,37k | -1,09% |
| 2026-02-11 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,27M | Automatic Disposition | 62,96 - 64,99 | 1,01M | -1,95% |
| 2026-02-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -4,13k | 175,12k | Derivative Exercise and Sale | 22,86 - 66,85 | 150,47k | - |
| 2026-02-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -1,38k | 92,44k | Automatic Disposition | 66,85 - 68,94 | 150,47k | -0,91% |
| 2026-02-02 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 131,63k | Automatic Disposition | 65,21 - 66,89 | 183,37k | -1,08% |
| 2026-01-22 | Fairmount Funds Management LLCUnternehmen | -1,75M | 133,53M | Verkauf | 76,30 | 298,65k | -85,42% |
| 2026-01-14 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,62M | Automatic Disposition | 78,64 - 83,79 | 989,94k | -1,98% |
| 2026-01-07 | Dr. Carl Linden DambkowskiChief Medical Officer | -14,03k | 769,66k | Derivative Exercise and Sale | 22,86 - 77,90 | 145,58k | - |
| 2026-01-07 | Dr. Carl Linden DambkowskiChief Medical Officer | -4,68k | 365,34k | Automatic Disposition | 77,90 - 80,06 | 145,58k | -3,11% |
| 2026-01-02 | Ms. Jane Pritchett V. HendersonCFO | -8,00k | 609,15k | Automatic Disposition | 74,13 - 80,00 | 185,37k | -4,14% |
| 2025-12-19 | Ms. Jane Pritchett V. HendersonCFO | -1,50k | 120,00k | Automatic Disposition | 80,00 | 193,37k | -0,77% |
| 2025-12-10 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,51M | Automatic Disposition | 74,88 - 76,58 | 1,01M | -1,94% |
| 2025-12-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -10,90k | 817,50k | Automatic Disposition | 75,00 | 197,89k | -5,22% |
| 2025-12-04 | Ms. Jane Pritchett V. HendersonCFO | -1,50k | 112,50k | Automatic Disposition | 75,00 | 194,87k | -0,76% |
| 2025-12-04 | Dr. Michael Thomas HendersonCEO & Director | -40,00k | 3,00M | Automatic Disposition | 75,01 | 1,03M | -3,74% |
| 2025-11-25 | Ms. Jane Pritchett V. HendersonCFO | -1,50k | 105,00k | Automatic Disposition | 70,00 | 196,37k | -0,76% |
| 2025-11-14 | Ms. Jane Pritchett V. HendersonCFO | -2,00k | 130,00k | Automatic Disposition | 65,00 | 197,87k | -1,00% |
| 2025-11-11 | Ms. Jane Pritchett V. HendersonCFO | -1.000,00 | 60,00k | Automatic Disposition | 60,00 | 199,87k | -0,50% |
| 2025-11-13 | Dr. Michael Thomas HendersonCEO & Director | -20,00k | 1,26M | Automatic Disposition | 61,93 - 64,52 | 1,04M | -1,89% |
| 2025-11-05 | Dr. Carl Linden DambkowskiChief Medical Officer | -8,06k | 257,57k | Derivative Exercise and Sale | 22,86 - 55,58 | 196,26k | - |
| 2025-11-05 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 152,09k | Automatic Disposition | 55,58 - 56,51 | 196,26k | -1,37% |
| 2025-10-10 | Mr. Nimish P. ShahIndependent Director | 365,85k | 0,00 | Open Market Derivative Acquisition | - | 365,85k | - |
| 2025-10-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,39k | 40,40k | Derivative Exercise and Sale | 22,86 - 39,80 | 198,99k | - |
| 2025-10-01 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 108,46k | Automatic Disposition | 39,80 | 198,99k | -1,35% |
| 2025-09-03 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 103,20k | Automatic Disposition | 37,82 - 38,55 | 141,54k | -1,89% |
| 2025-08-06 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 102,95k | Automatic Disposition | 37,78 | 131,73k | -2,03% |
| 2025-07-02 | Dr. Carl Linden DambkowskiChief Medical Officer | -7,37k | 162,06k | Derivative Exercise and Sale | 22,86 - 45,49 | 134,45k | - |
| 2025-07-02 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 124,53k | Automatic Disposition | 45,49 - 46,26 | 134,45k | -1,99% |
| 2025-06-04 | Dr. Carl Linden DambkowskiChief Medical Officer | -2,73k | 100,72k | Automatic Disposition | 36,96 | 124,64k | -2,14% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
